Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Apple Inc. stock logo
AAPL
Apple
$203.92
+1.6%
$201.17
$169.21
$260.10
$3.05T1.2256.15 million shs46.48 million shs
Amgen Inc. stock logo
AMGN
Amgen
$290.33
+1.1%
$281.57
$253.30
$346.85
$154.38B0.512.81 million shs2.00 million shs
American Express stock logo
AXP
American Express
$302.71
+2.3%
$273.60
$220.43
$326.28
$212.08B1.252.83 million shs2.10 million shs
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Apple Inc. stock logo
AAPL
Apple
+1.64%+2.47%+3.90%-14.70%+4.11%
Amgen Inc. stock logo
AMGN
Amgen
+1.13%+1.15%+5.25%-10.63%-5.55%
American Express stock logo
AXP
American Express
+2.30%+2.95%+9.58%+10.83%+29.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Apple Inc. stock logo
AAPL
Apple
4.7912 of 5 stars
3.34.03.32.82.12.51.9
Amgen Inc. stock logo
AMGN
Amgen
4.2728 of 5 stars
2.23.03.33.93.42.50.6
American Express stock logo
AXP
American Express
4.6042 of 5 stars
2.13.02.53.02.93.32.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Apple Inc. stock logo
AAPL
Apple
2.53
Moderate Buy$235.0215.25% Upside
Amgen Inc. stock logo
AMGN
Amgen
2.38
Hold$309.226.51% Upside
American Express stock logo
AXP
American Express
2.29
Hold$296.05-2.20% Downside

Current Analyst Ratings Breakdown

Latest AXP, AMGN, and AAPL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/6/2025
Apple Inc. stock logo
AAPL
Apple
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy$250.00
6/5/2025
Apple Inc. stock logo
AAPL
Apple
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$235.00
6/4/2025
Apple Inc. stock logo
AAPL
Apple
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$225.00
6/1/2025
Apple Inc. stock logo
AAPL
Apple
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/23/2025
American Express stock logo
AXP
American Express
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$315.00 ➝ $335.00
5/21/2025
Apple Inc. stock logo
AAPL
Apple
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/20/2025
Amgen Inc. stock logo
AMGN
Amgen
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$288.00
5/16/2025
Apple Inc. stock logo
AAPL
Apple
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$270.00 ➝ $270.00
5/16/2025
Amgen Inc. stock logo
AMGN
Amgen
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$329.00 ➝ $328.00
5/12/2025
Apple Inc. stock logo
AAPL
Apple
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight
5/8/2025
Amgen Inc. stock logo
AMGN
Amgen
Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
(Data available from 6/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Apple Inc. stock logo
AAPL
Apple
$400.37B7.61$6.34 per share32.16$3.77 per share54.09
Amgen Inc. stock logo
AMGN
Amgen
$34.13B4.57$29.09 per share9.98$10.93 per share26.56
American Express stock logo
AXP
American Express
$67.12B3.16$16.49 per share18.36$42.96 per share7.05
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Apple Inc. stock logo
AAPL
Apple
$93.74B$6.4232.3724.872.4424.30%160.83%30.88%7/30/2025 (Estimated)
Amgen Inc. stock logo
AMGN
Amgen
$4.09B$10.9638.4513.572.6312.24%176.32%11.71%8/5/2025 (Estimated)
American Express stock logo
AXP
American Express
$10.13B$14.3221.6117.201.4115.36%32.65%3.56%7/18/2025 (Estimated)

Latest AXP, AMGN, and AAPL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2025Q2 2025
Apple Inc. stock logo
AAPL
Apple
$1.62$1.65+$0.03$1.65$94.04 billion$95.36 billion
5/1/2025Q1 2025
Amgen Inc. stock logo
AMGN
Amgen
$4.18$4.90+$0.72$3.20$8.05 billion$8.15 billion
4/17/2025Q1 2025
American Express stock logo
AXP
American Express
$3.47$3.64+$0.17$3.64$17.04 billion$16.97 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Apple Inc. stock logo
AAPL
Apple
$1.040.51%+4.60%16.20%14 Years
Amgen Inc. stock logo
AMGN
Amgen
$9.523.28%+8.53%86.86%14 Years
American Express stock logo
AXP
American Express
$3.281.08%N/A22.91%4 Years

Latest AXP, AMGN, and AAPL Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/1/2025
Apple Inc. stock logo
AAPL
Apple
quarterly$0.260.49%5/12/20255/12/20255/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Apple Inc. stock logo
AAPL
Apple
1.26
0.92
0.88
Amgen Inc. stock logo
AMGN
Amgen
9.62
1.26
0.95
American Express stock logo
AXP
American Express
1.64
1.58
1.57

Institutional Ownership

CompanyInstitutional Ownership
Apple Inc. stock logo
AAPL
Apple
67.73%
Amgen Inc. stock logo
AMGN
Amgen
76.50%
American Express stock logo
AXP
American Express
84.33%

Insider Ownership

CompanyInsider Ownership
Apple Inc. stock logo
AAPL
Apple
0.06%
Amgen Inc. stock logo
AMGN
Amgen
0.76%
American Express stock logo
AXP
American Express
0.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
Apple Inc. stock logo
AAPL
Apple
164,00014.94 billion15.01 billionOptionable
Amgen Inc. stock logo
AMGN
Amgen
25,200537.71 million533.50 millionOptionable
American Express stock logo
AXP
American Express
77,300700.59 million701.76 millionOptionable

Recent News About These Companies

Is American Express Worth Buying Right Now?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Apple stock logo

Apple NASDAQ:AAPL

$203.92 +3.29 (+1.64%)
Closing price 06/6/2025 04:00 PM Eastern
Extended Trading
$204.51 +0.59 (+0.29%)
As of 06/6/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Apple Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide. The company offers iPhone, a line of smartphones; Mac, a line of personal computers; iPad, a line of multi-purpose tablets; and wearables, home, and accessories comprising AirPods, Apple TV, Apple Watch, Beats products, and HomePod. It also provides AppleCare support and cloud services; and operates various platforms, including the App Store that allow customers to discover and download applications and digital content, such as books, music, video, games, and podcasts. In addition, the company offers various services, such as Apple Arcade, a game subscription service; Apple Fitness+, a personalized fitness service; Apple Music, which offers users a curated listening experience with on-demand radio stations; Apple News+, a subscription news and magazine service; Apple TV+, which offers exclusive original content; Apple Card, a co-branded credit card; and Apple Pay, a cashless payment service, as well as licenses its intellectual property. The company serves consumers, and small and mid-sized businesses; and the education, enterprise, and government markets. It distributes third-party applications for its products through the App Store. The company also sells its products through its retail and online stores, and direct sales force; and third-party cellular network carriers, wholesalers, retailers, and resellers. Apple Inc. was founded in 1976 and is headquartered in Cupertino, California.

Amgen stock logo

Amgen NASDAQ:AMGN

$290.33 +3.23 (+1.13%)
Closing price 06/6/2025 04:00 PM Eastern
Extended Trading
$292.05 +1.72 (+0.59%)
As of 06/6/2025 07:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

American Express stock logo

American Express NYSE:AXP

$302.71 +6.75 (+2.28%)
Closing price 06/6/2025 03:59 PM Eastern
Extended Trading
$301.57 -1.14 (-0.38%)
As of 06/6/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

American Express Company, together with its subsidiaries, operates as integrated payments company in the United States, Europe, the Middle East and Africa, the Asia Pacific, Australia, New Zealand, Latin America, Canada, the Caribbean, and Internationally. It operates through four segments: U.S. Consumer Services, Commercial Services, International Card Services, and Global Merchant and Network Services. The company's products and services include credit card, charge card, banking, and other payment and financing products; network services; expense management products and services; and travel and lifestyle services. It also provides merchant acquisition and processing, servicing and settlement, point-of-sale marketing, and information products and services for merchants; and fraud prevention services, as well as the design and operation of customer loyalty programs. In addition, the company operates lounges at airports under Centurion Lounge brand name. It sells its products and services to consumers, small businesses, mid-sized companies, and large corporations through mobile and online applications, affiliate marketing, customer referral programs, third-party service providers and business partners, direct mail, telephone, in-house sales teams, and direct response advertising. American Express Company was founded in 1850 and is headquartered in New York, New York.